| Peer-Reviewed

Management of Hydrocephalus in Brain Tumors to Fann Teaching Hospital in Dakar

Received: 9 October 2019     Accepted: 28 November 2019     Published: 21 January 2020
Views:       Downloads:
Abstract

Introduction: Tumoral hydrocephalus (TH) is an increasingly common pathology in our service. It is a diagnostic and especially therapeutic emergency. Its treatment is mainly surgical and the prognosis closely depends on the type of tumor. The objective of our study was to determine the efficiency of the various bypass procedures used for the treatment of hydrocephalus in patients with brain tumors. Patients and Methods: We conducted a retrospective study of 146 patients with tumoral hydrocephalus, collected from 1 January 2014 to 31 December 2018 (5 years) in the Neurosurgery Department of Fann Teaching Hospital. Results: The frequency of tumoral hydrocephalus cases in our series was rated at 25% of all hydrocephalus operated during this period with 29.2 cases per year. The sex ratio was 1.39 with a mean age of 35 years (range from 1 month to 77 years). Children under 15 accounted for 53.42%. Cerebral computed tomography (CT) was performed in 93.75% of patients and magnetic resonance imaging (MRI) in 20.83%. Tumors of the posterior fossa (PFT) accounted for 60.3% followed by ventricular tumors 15.5% and sellar 7.5%. Surgically, endoscopic third ventriculostomy (ETV), ventriculoperitoneal shunt (VPS), and external ventricular derivation (EVD) were performed respectively in 58.24%, 30.13% and 10.27% of cases. The surgical average time was 3 days with extremes of 24h and 150 days. Two patients benefited from a ventriculo –atrial shunt (VAS) complementary to the persistence of hydrocephalus. The main complications were ascites of great abundance in 4 patients and infections in 10 patients (6.84%). In our series, 30.82% (45 patients) received additional etiological treatment. The average time between the two interventions was 14 days. We noted 17 cases of death including 7 cases attributed to hydrocephalus. Conclusion: The endoscopic third ventriculostomy is currently the gold standard as an alternative to other methods in the management of tumoral hydrocephalus, but remains a palliative treatment. Etiological treatment is the core therapeutic approach for this hydrocephalus.

Published in International Journal of Neurosurgery (Volume 4, Issue 1)
DOI 10.11648/j.ijn.20200401.11
Page(s) 1-6
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

Hydrocephalus, Brain Tumor, Endoscopic Third Ventriculostomy

References
[1] Bauer BL, Hellwig D. Minimally invasive endoscopic neurosurgery--a survey. Acta Neurochir Suppl. 1994; 61: 1-12.
[2] Baroncini, M., Vinchon, M., Minéo, JF. et al. Childs Nerv Syst (2007) 23: 753. https://doi.org/10.1007/s00381-007-0299-4.
[3] Baroncini M, Peltier J, Le gars D, Lejeune JP: Tumeurs du ventricule latéral. Analyse d’une série de 284 cas. Neurochir 2011; 57 (4-6): 170-179.
[4] Benjamin C. Kennedy, Jeffrey N. Bruce. Surgical Approaches to the Pineal Region Neurosurgery Clinics of North America, July 2011; 22 (3): 367–80.
[5] Choux M, Lena G. Bases of surgical management of craniopharyngioma in children proceedings. Acta Neurochir Suppl (Wien). 1979; 28 (2): 348.
[6] Christian Matula. Chapter 37 – Tumors of the Pineal Region. Principles of Neurological Surgery (Third Edition) 2012: 565–84.
[7] Creissard. P, Godleuski J, Tadie M, Freger P Faut-il aborder les kystes colloides du 3e ventricule. Neurochirurgie, 1981, 27: 225-228.
[8] Deopujari CE, Karmarkar VS, Shaikh ST Endoscopic Third Ventriculostomy: Success and Failure; J Korean Neurosurg Soc. 2017 May; 60 (3): 306-314; DOI: 10.3340/jkns.2017.0202.013.
[9] Ekouel-Mbaki H. B, M. Elombila, G. F Etiobanda, G. A Panzou, P. M. Ossou-Guiet Prise en charge neuro-chirurgicale des tumeurs cranio-encéphaliques au Centre Hospitalier Universitaire de Brazzaville (Congo); Médecine d'Afrique Noire, Juin 2018, Vol 65, No6: 291-298.
[10] Carl El Khoury, Pierre Brugières, Philippe Decq, Ruxandra Cosson-Stanescu, Catherine Combes, Frédéric Ricolfi and André Gaston. Colloid Cysts of the Third Ventricle: Are MR Imaging Patterns Predictive of Difficulty with Percutaneous Treatment? American Journal of Neuroradiology, March 2000, 21 (3) 489-492.
[11] Fournier D, Pasco-papan A, Menei P, Mercier P, Guy G. Tumeurs intraventriculaire EMC-Neurologie 1997 [Article17250-A-10].
[12] Goel A (2000); Preoperative shunts in thalamic tumors. Neurol India 48: 347–350.
[13] Gonzalez LF, Gregory P. Lekovic and col; Surgical Approaches to the cerebellopontine Angle. In: Nicholas C. Bambakidis, Md, Cliff A. Megerian, Robert F. Spetzler. Surgery of the Cerebellopontine Angle. BC Decker. 2009. p53-72.
[14] Guyotat J, Vasiljevic A, Frappaz D, Durand A, Fèvre Montange M, Jouvet A. Tumeurs de la région pinéale. EMC – Neurologie 2011; 17-380-D-10.
[15] Jan Gliemroth, Eva Käsbeck, Uwe Kehler Ventriculocisternostomy versus ventriculoperitoneal shunt in the treatment of hydrocephalus: A retrospective, long-term observational study; Clinical Neurology and Neurosurgery, Volume 122, July 2014, Pages 92-96.
[16] Lena G, Paz Paredes A, Scavarda D, Giusiano B. Craniopharyngioma in children: Marseille experience. Childs Nerv Syst. 2005 Aug; 21 (8-9): 778-84.
[17] M Mbaye, M Thioub, AB Thiam, CN Sy, R G Boukaka, J. Kissao, MC BA, SB Badiane; Treatment of tumor hydrocephalia by endoscopic ventriculo-cisternostomy; Journal Africain de Chirurgie 2017; 4 (3): 131-136.
[18] Morelli D., Lubansu A., Van Bogaert P., Frickx C., David P., Brotchi J., Pirotte B. Hydrocéphalie persistante après exérèse chirurgicale précoce des tumeurs de la fosse postérieure: analyse critique rétrospective d’une série consécutive de 160 enfants. CONGRÈS SNCLF; Vol. 50, n° 5, 2004, P 57.
[19] Ousseini Diallo, Ouattara Boubakar, Zanga Moussa, Tiemtore-Kambou Bénilde, N’de/Ouedraogo Nina, Dao Ben Aziz, Napon A Madina, Bamouni Y Abel, Lougue/Sorgho Claudine, Cisse Rabiou; Etiological diagnosis of macrocranies explored by CT in Burkina Faso (70 cases) Journal Africain d’Imagerie Médicale 2016, Volume 8 (4): 159-163.
[20] Pirouzmand F, Tator CH, Rutka J. Management of hydrocephalus associated with vestibular schwannoma and other Cerebellopontine Angle Tumors. Neurosurgery. 2001 Jun 1; 48 (6): 1246-1254.
[21] Quenum K, Y Sogoba, M Hemama, A Hossinand, Laghmari M, Gana R, Maaqili R, Bellakhdar F Tumeurs de la région pinéale: expérience des dix dernières années. À propos de 22 cas. Neurochirurgie 2008; 54 (5): 684–5.
[22] Alexandre Roux, Céline Botella, Megan Still, Marc Zanello, Frédéric Dhermain, Philippe Metellus, Johan Pallud. Posterior Fossa Metastasis-Associated Obstructive Hydrocephalus in Adult Patients: Literature Review and Practical Considerations from the Neuro-Oncology Club of the French Society of Neurosurgery. World Neurosurg. 2018 Sep; 117: 271-279. doi: 10.1016/j.wneu.2018.06.084. Epub 2018 Jun [PubMed].
[23] S. Salem-Memou, A. Badara Thiam, E. Kpelao, M. Mbaye M. C. Ba S. B. Badiane; Treatment of child hydrocephalus by endoscopic third ventriculostomy in Senegal; Volume 60, Issue 5, October 2014, Pages 254-257.
[24] Stephanie Puget, Kevin Beccaria, Claire Alapetite, Dulanjalee Kariyawasam, Michel Polak, Delphine Zenaty, Raphael Calmon, Christian Sainte-Rose. Les craniopharyngiomes de l'enfant: stratégie de prise en charge: Journée National du DES (JNDES), Médecine Clinique Endocrinologie et Diabète (MCED)/ MCED No86 Janvier 2017: P 12-15.
[25] Zuccaro Graciela, Sosa Fidel, Cuccia Vicente, Lubienecky Fabiana, Monges Jorge; Lateral ventricle tumors in children: a series of 54 cases Child’s Nerv Syst (1990) 15: 774-785.
Cite This Article
  • APA Style

    Alioune Badara Thiam, Maguette Mbaye, Rel Gerald Boukaka Kala, Mbaye Thioub, Cheick Ndiaye SY, et al. (2020). Management of Hydrocephalus in Brain Tumors to Fann Teaching Hospital in Dakar. International Journal of Neurosurgery, 4(1), 1-6. https://doi.org/10.11648/j.ijn.20200401.11

    Copy | Download

    ACS Style

    Alioune Badara Thiam; Maguette Mbaye; Rel Gerald Boukaka Kala; Mbaye Thioub; Cheick Ndiaye SY, et al. Management of Hydrocephalus in Brain Tumors to Fann Teaching Hospital in Dakar. Int. J. Neurosurg. 2020, 4(1), 1-6. doi: 10.11648/j.ijn.20200401.11

    Copy | Download

    AMA Style

    Alioune Badara Thiam, Maguette Mbaye, Rel Gerald Boukaka Kala, Mbaye Thioub, Cheick Ndiaye SY, et al. Management of Hydrocephalus in Brain Tumors to Fann Teaching Hospital in Dakar. Int J Neurosurg. 2020;4(1):1-6. doi: 10.11648/j.ijn.20200401.11

    Copy | Download

  • @article{10.11648/j.ijn.20200401.11,
      author = {Alioune Badara Thiam and Maguette Mbaye and Rel Gerald Boukaka Kala and Mbaye Thioub and Cheick Ndiaye SY and Mohamet Faye and Sarah Mutomb Ntshindj and Ndaraw Ndoye and Momar Codé BA and Seydou Boubakar Badiane},
      title = {Management of Hydrocephalus in Brain Tumors to Fann Teaching Hospital in Dakar},
      journal = {International Journal of Neurosurgery},
      volume = {4},
      number = {1},
      pages = {1-6},
      doi = {10.11648/j.ijn.20200401.11},
      url = {https://doi.org/10.11648/j.ijn.20200401.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijn.20200401.11},
      abstract = {Introduction: Tumoral hydrocephalus (TH) is an increasingly common pathology in our service. It is a diagnostic and especially therapeutic emergency. Its treatment is mainly surgical and the prognosis closely depends on the type of tumor. The objective of our study was to determine the efficiency of the various bypass procedures used for the treatment of hydrocephalus in patients with brain tumors. Patients and Methods: We conducted a retrospective study of 146 patients with tumoral hydrocephalus, collected from 1 January 2014 to 31 December 2018 (5 years) in the Neurosurgery Department of Fann Teaching Hospital. Results: The frequency of tumoral hydrocephalus cases in our series was rated at 25% of all hydrocephalus operated during this period with 29.2 cases per year. The sex ratio was 1.39 with a mean age of 35 years (range from 1 month to 77 years). Children under 15 accounted for 53.42%. Cerebral computed tomography (CT) was performed in 93.75% of patients and magnetic resonance imaging (MRI) in 20.83%. Tumors of the posterior fossa (PFT) accounted for 60.3% followed by ventricular tumors 15.5% and sellar 7.5%. Surgically, endoscopic third ventriculostomy (ETV), ventriculoperitoneal shunt (VPS), and external ventricular derivation (EVD) were performed respectively in 58.24%, 30.13% and 10.27% of cases. The surgical average time was 3 days with extremes of 24h and 150 days. Two patients benefited from a ventriculo –atrial shunt (VAS) complementary to the persistence of hydrocephalus. The main complications were ascites of great abundance in 4 patients and infections in 10 patients (6.84%). In our series, 30.82% (45 patients) received additional etiological treatment. The average time between the two interventions was 14 days. We noted 17 cases of death including 7 cases attributed to hydrocephalus. Conclusion: The endoscopic third ventriculostomy is currently the gold standard as an alternative to other methods in the management of tumoral hydrocephalus, but remains a palliative treatment. Etiological treatment is the core therapeutic approach for this hydrocephalus.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Management of Hydrocephalus in Brain Tumors to Fann Teaching Hospital in Dakar
    AU  - Alioune Badara Thiam
    AU  - Maguette Mbaye
    AU  - Rel Gerald Boukaka Kala
    AU  - Mbaye Thioub
    AU  - Cheick Ndiaye SY
    AU  - Mohamet Faye
    AU  - Sarah Mutomb Ntshindj
    AU  - Ndaraw Ndoye
    AU  - Momar Codé BA
    AU  - Seydou Boubakar Badiane
    Y1  - 2020/01/21
    PY  - 2020
    N1  - https://doi.org/10.11648/j.ijn.20200401.11
    DO  - 10.11648/j.ijn.20200401.11
    T2  - International Journal of Neurosurgery
    JF  - International Journal of Neurosurgery
    JO  - International Journal of Neurosurgery
    SP  - 1
    EP  - 6
    PB  - Science Publishing Group
    SN  - 2640-1959
    UR  - https://doi.org/10.11648/j.ijn.20200401.11
    AB  - Introduction: Tumoral hydrocephalus (TH) is an increasingly common pathology in our service. It is a diagnostic and especially therapeutic emergency. Its treatment is mainly surgical and the prognosis closely depends on the type of tumor. The objective of our study was to determine the efficiency of the various bypass procedures used for the treatment of hydrocephalus in patients with brain tumors. Patients and Methods: We conducted a retrospective study of 146 patients with tumoral hydrocephalus, collected from 1 January 2014 to 31 December 2018 (5 years) in the Neurosurgery Department of Fann Teaching Hospital. Results: The frequency of tumoral hydrocephalus cases in our series was rated at 25% of all hydrocephalus operated during this period with 29.2 cases per year. The sex ratio was 1.39 with a mean age of 35 years (range from 1 month to 77 years). Children under 15 accounted for 53.42%. Cerebral computed tomography (CT) was performed in 93.75% of patients and magnetic resonance imaging (MRI) in 20.83%. Tumors of the posterior fossa (PFT) accounted for 60.3% followed by ventricular tumors 15.5% and sellar 7.5%. Surgically, endoscopic third ventriculostomy (ETV), ventriculoperitoneal shunt (VPS), and external ventricular derivation (EVD) were performed respectively in 58.24%, 30.13% and 10.27% of cases. The surgical average time was 3 days with extremes of 24h and 150 days. Two patients benefited from a ventriculo –atrial shunt (VAS) complementary to the persistence of hydrocephalus. The main complications were ascites of great abundance in 4 patients and infections in 10 patients (6.84%). In our series, 30.82% (45 patients) received additional etiological treatment. The average time between the two interventions was 14 days. We noted 17 cases of death including 7 cases attributed to hydrocephalus. Conclusion: The endoscopic third ventriculostomy is currently the gold standard as an alternative to other methods in the management of tumoral hydrocephalus, but remains a palliative treatment. Etiological treatment is the core therapeutic approach for this hydrocephalus.
    VL  - 4
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Department of Neurosurgery, Fann Teaching Hospital, University Cheikh Anta Diop, Dakar, Senegal

  • Sections